|
|||||
|
|
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer |
|
| Authors: | C. Emmanouilides M. Pegram R. Robinson R. Hecht F. Kabbinavar W. Isacoff |
| Affiliation: | 1.Division of Hematology/Oncology,UCLA Medical Center,Los Angeles,USA;2.Interbalkan Medical Center (Diavalkaniko),Pylaia, Thessaloniki,Greece |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |